29.04.2025 – 14:00Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Sitemore
26.01.2024 – 13:50Biomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymore
13.11.2023 – 13:38Biomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Servicesmore
